Maciej Wieczorek, Ph.D. – President, CEO
Initiator and founder and pesident of biopharmaceutical company Celon Pharma, which as one of few exception companies in Poland which develops innovative biotechnological drugs. Previously, he was co – owner and vice – pesident of the board in Adamed Ltd., where he was responsible for strategy of product, marketing, research and development. Maciej Wieczorek is author and co – author of several patents concerning chemical and biotechnological drugs. Also, he introduced to the market the best selling drugs in Poland.
Jarosław Walczak – Member of the Board
Jarosław Walczak graduated from the Department of Biotechnology and Food Chemistry, Technical University of Łódź. He is associated with Polfarmex company since 1993. He is focused on works concerning registration documentation of medicinal products (product composition, manufacturing technology, quality requirements and research methods) as well as clinical trials, including bioequivalency tests (test documentation, monitoring).
Dr. Eng. Slawomir Jaros – Member of the Board – is educated biotechnologist, he participated in many biotechnology projects – including the creation of recombinant proteins and vaccines.
Dr. Jaros is associated with the company Mabion since the end of 2007 and throughout the period he was head of research and development laboratory.
Artur Chabowski – Member of the Board
Artur Chabowski graduated from the Organization and Management at the Warsaw University of Technology. A scholarship holder of the Woodrow Wislon School of Public and International Affairs at Princeton University, where he obtained a Certificate in Science, Technology and Public Policy. He worked as the Deputy Director of the CAIB Financial Advisers, Director in KPMG and a member of the board of ABN AMRO Corporate Finance. Since 2008 he is a chairman of the board of the ACADIA company.